RGBP · CIK 0001589150

REGEN BIOPHARMA, INC.

Annual figures as reported, FY2014–FY2025. Ratios and growth rates derived on-page.

Revenue

$237K

▲ +0.0% vs FY2024

Net income

−$1.3M

▼ −90.7% vs FY2024

Operating cash flow

−$384K

▲ +49.0% vs FY2024

Diluted EPS

−$0.05

▲ +68.8% vs FY2024

Revenue

Annual, as reported

Net income

Losses shown in terracotta

Recent quarters

momentum · last 12 quarters

Revenue — Mar ’26 quarter

$59K

▲ +0.0% vs Mar ’25

Net income — Mar ’26 quarter

$992K

▲ +5225.2% vs Mar ’25

Revenue — trailing 12 months

$237K

▲ +0.0% vs Mar ’25

Diluted EPS — trailing 12 months

$0.07

▲ +131.8% vs Mar ’25

Quarterly revenue

Discrete quarters; Q4 derived from the annual figure

Quarterly net income

Losses shown in terracotta

Quarter	Revenue	Rev. YoY	Gross margin	Net income	Net margin	Diluted EPS
Mar ’26	$59K	0.0%	—	$992K	1679.4%	$0.00
Dec ’25	$59K	0.0%	—	−$968K	−1638.6%	−$0.01
Sep ’25	$59K	0.0%	—	−$572K	−964.3%	$0.09
Jun ’25	$59K	0.0%	—	−$167K	−283.2%	−$0.01
Mar ’25	$59K	0.0%	—	−$19K	−32.8%	$0.00
Dec ’24	$59K	0.0%	—	−$515K	−872.6%	−$0.13
Sep ’24	$59K	−58.1%	—	−$271K	−456.1%	−$0.06
Jun ’24	$59K	86.7%	—	−$130K	−220.3%	−$0.03

Profitability & returns

quality of earnings

Margins

Share of revenue kept at each line

Operating marginNet margin

Returns on capital

Net income vs year-end equity and assets

Cash flow

cash generation

Operating cash flow

Net cash from operations

Shareholder returns

capital allocation

Diluted shares outstanding

Falling count means buybacks outpace dilution

Balance sheet

financial position

Stockholders’ equity

At fiscal year end

Growth rates

compounding, annualized

Revenue CAGR

+23.5%

+16.5%

+2.1%

10y

Share count change (split-adjusted)

−98.3%

−73.3%

10y

Key ratios

derived per fiscal year

Fiscal year	Op. margin	Net margin	ROA	Current ratio
FY2025	−143.1%	−538.8%	−464.1%	0.04×
FY2024	−176.4%	−282.5%	−414.8%	0.03×
FY2023	−290.4%	488.9%	327.1%	0.02×
FY2022	−270.6%	1946.8%	437.1%	0.04×
FY2021	−328.1%	−11055.4%	−558.1%	0.07×
FY2020	−190.3%	3104.0%	2771.7%	0.01×
FY2019	−688.0%	−2384.7%	−2647.3%	0.01×
FY2018	−1425.8%	−4715.2%	−2255.9%	0.00×
FY2017	−2282.6%	−5308.2%	−618.4%	0.08×
FY2016	−2957.0%	−7750.6%	−2426.9%	0.26×
FY2015	−1030.9%	−5830.8%	−5078.3%	0.20×
FY2014	—	—	−7098.6%	0.08×

Annual figures

as reported

Fiscal year	Revenue	Gross profit	Op. income	Net income	Diluted EPS	Op. cash flow	Capex	Total assets	Liabilities	Equity	Cash	LT debt
FY2025	$237K	—	−$339K	−$1.3M	−$0.05	−$384K	—	$275K	$6.6M	−$6.3M	$70K	—
FY2024	$237K	—	−$417K	−$668K	−$0.16	−$752K	—	$161K	$5.4M	−$5.2M	$716	—
FY2023	$237K	—	−$687K	$1.2M	$0.29	−$174K	—	$354K	$5.5M	−$4.9M	$121K	—
FY2022	$126K	—	−$340K	$2.4M	$0.71	−$607K	—	$559K	$8.6M	−$76.7M	$51K	—
FY2021	$61K	—	−$201K	−$6.8M	−$0.00	−$1.1M	—	$1.2M	$14.7M	−$12.4M	$727K	—
FY2020	$110K	—	−$209K	$3.4M	$0.00	$19K	—	$123K	$7.5M	−$11.8M	$0	—
FY2019	$110K	—	−$757K	−$2.6M	−$0.00	−$482K	—	$99K	$11.0M	−$10.9M	$8K	—
FY2018	$100K	—	−$1.4M	−$4.7M	−$0.03	−$1.6M	—	$209K	$9.3M	−$9.1M	$8K	—
FY2017	$110K	—	−$2.5M	−$5.8M	−$0.04	−$1.9M	—	$944K	$6.2M	—	$270K	—
FY2016	$100K	—	−$3.0M	−$7.8M	−$0.06	−$1.7M	—	$319K	$906K	—	$25K	—
FY2015	$192K	—	−$2.0M	−$11.2M	−$0.13	−$1.2M	—	$220K	$318K	—	—	—
FY2014	$0	—	−$706K	−$756K	−$0.01	—	—	$11K	$140K	—	—	—

Latest filings

the most recent regulatory filings

10-QQuarterly report2026-05-14 ↗8-KCurrent report — material event2026-03-04 ↗10-QQuarterly report2026-02-13 ↗8-KCurrent report — material event2026-02-02 ↗8-KCurrent report — material event2026-01-21 ↗QUALIFSEC filing2026-01-12 ↗1-A POSSEC filing2026-01-08 ↗10-KAnnual report2025-12-30 ↗253G1Delisting notice2025-12-05 ↗QUALIFSEC filing2025-12-03 ↗

Company logos by Elbstream and unavatar.

All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.

Quarter

Revenue

Rev. YoY

Gross margin

Net income

Net margin

Diluted EPS

Mar ’26

$59K

0.0%

—

$992K

1679.4%

$0.00

Dec ’25

$59K

0.0%

—

−$968K

−1638.6%

−$0.01

Sep ’25

$59K

0.0%

—

−$572K

−964.3%

$0.09

Jun ’25

$59K

0.0%

—

−$167K

−283.2%

−$0.01

Mar ’25

$59K

0.0%

—

−$19K

−32.8%

$0.00

Dec ’24

$59K

0.0%

—

−$515K

−872.6%

−$0.13

Sep ’24

$59K

−58.1%

—

−$271K

−456.1%

−$0.06

Jun ’24

$59K

86.7%

—

−$130K

−220.3%

−$0.03

Fiscal year

Op. margin

Net margin

ROA

Current ratio

FY2025

−143.1%

−538.8%

−464.1%

0.04×

FY2024

−176.4%

−282.5%

−414.8%

0.03×

FY2023

−290.4%

488.9%

327.1%

0.02×

FY2022

−270.6%

1946.8%

437.1%

0.04×

FY2021

−328.1%

−11055.4%

−558.1%

0.07×

FY2020

−190.3%

3104.0%

2771.7%

0.01×

FY2019

−688.0%

−2384.7%

−2647.3%

0.01×

FY2018

−1425.8%

−4715.2%

−2255.9%

0.00×

FY2017

−2282.6%

−5308.2%

−618.4%

0.08×

FY2016

−2957.0%

−7750.6%

−2426.9%

0.26×

FY2015

−1030.9%

−5830.8%

−5078.3%

0.20×

FY2014

—

−7098.6%

0.08×

Fiscal year

Revenue

Gross profit

Op. income

Net income

Diluted EPS

Op. cash flow

Capex

Total assets

Liabilities

Equity

Cash

LT debt

FY2025

$237K

—

−$339K

−$1.3M

−$0.05

−$384K

—

$275K

$6.6M

−$6.3M

$70K

—

FY2024

$237K

—

−$417K

−$668K

−$0.16

−$752K

—

$161K

$5.4M

−$5.2M

$716

—

FY2023

$237K

—

−$687K

$1.2M

$0.29

−$174K

—

$354K

$5.5M

−$4.9M

$121K

—

FY2022

$126K

—

−$340K

$2.4M

$0.71

−$607K

—

$559K

$8.6M

−$76.7M

$51K

—

FY2021

$61K

—

−$201K

−$6.8M

−$0.00

−$1.1M

—

$1.2M

$14.7M

−$12.4M

$727K

—

FY2020

$110K

—

−$209K

$3.4M

$0.00

$19K

—

$123K

$7.5M

−$11.8M

—

FY2019

$110K

—

−$757K

−$2.6M

−$0.00

−$482K

—

$99K

$11.0M

−$10.9M

$8K

—

FY2018

$100K

—

−$1.4M

−$4.7M

−$0.03

−$1.6M

—

$209K

$9.3M

−$9.1M

$8K

—

FY2017

$110K

—

−$2.5M

−$5.8M

−$0.04

−$1.9M

—

$944K

$6.2M

—

$270K

—

FY2016

$100K

—

−$3.0M

−$7.8M

−$0.06

−$1.7M

—

$319K

$906K

—

$25K

—

FY2015

$192K

—

−$2.0M

−$11.2M

−$0.13

−$1.2M

—

$220K

$318K

—

FY2014

—

−$706K

−$756K

−$0.01

—

$11K

$140K

—